198 related articles for article (PubMed ID: 23515013)
1. Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.
O'Hara JM; Brey RN; Mantis NJ
Clin Vaccine Immunol; 2013 Jun; 20(6):789-94. PubMed ID: 23515013
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB).
Yermakova A; Mantis NJ
Vaccine; 2011 Oct; 29(45):7925-35. PubMed ID: 21872634
[TBL] [Abstract][Full Text] [Related]
3. Combination of two candidate subunit vaccine antigens elicits protective immunity to ricin and anthrax toxin in mice.
Vance DJ; Rong Y; Brey RN; Mantis NJ
Vaccine; 2015 Jan; 33(3):417-21. PubMed ID: 25475957
[TBL] [Abstract][Full Text] [Related]
4. Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigen.
Thomas JC; O'Hara JM; Hu L; Gao FP; Joshi SB; Volkin DB; Brey RN; Fang J; Karanicolas J; Mantis NJ; Middaugh CR
Hum Vaccin Immunother; 2013 Apr; 9(4):744-52. PubMed ID: 23563512
[TBL] [Abstract][Full Text] [Related]
5. Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens.
Vance DJ; Greene CJ; Rong Y; Mandell LM; Connell TD; Mantis NJ
Clin Vaccine Immunol; 2015 Dec; 22(12):1285-93. PubMed ID: 26491037
[TBL] [Abstract][Full Text] [Related]
6. Durable Immunity to Ricin Toxin Elicited by a Thermostable, Lyophilized Subunit Vaccine.
Novak H; Doering J; Ehrbar D; Donini O; Mantis NJ
mSphere; 2021 Dec; 6(6):e0075021. PubMed ID: 34730377
[TBL] [Abstract][Full Text] [Related]
7. Novel Ricin Subunit Antigens With Enhanced Capacity to Elicit Toxin-Neutralizing Antibody Responses in Mice.
Wahome N; Sully E; Singer C; Thomas JC; Hu L; Joshi SB; Volkin DB; Fang J; Karanicolas J; Jacobs DJ; Mantis NJ; Middaugh CR
J Pharm Sci; 2016 May; 105(5):1603-1613. PubMed ID: 26987947
[TBL] [Abstract][Full Text] [Related]
8. High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit Vaccine.
Toth RT; Angalakurthi SK; Van Slyke G; Vance DJ; Hickey JM; Joshi SB; Middaugh CR; Volkin DB; Weis DD; Mantis NJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046307
[TBL] [Abstract][Full Text] [Related]
9. Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine.
Westfall J; Yates JL; Van Slyke G; Ehrbar D; Measey T; Straube R; Donini O; Mantis NJ
Vaccine; 2018 Sep; 36(40):5967-5976. PubMed ID: 30172637
[TBL] [Abstract][Full Text] [Related]
10. LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunity.
Greene CJ; Chadwick CM; Mandell LM; Hu JC; O'Hara JM; Brey RN; Mantis NJ; Connell TD
PLoS One; 2013; 8(8):e69678. PubMed ID: 23936344
[TBL] [Abstract][Full Text] [Related]
11. Progress and challenges associated with the development of ricin toxin subunit vaccines.
Vance DJ; Mantis NJ
Expert Rev Vaccines; 2016 Sep; 15(9):1213-22. PubMed ID: 26998662
[TBL] [Abstract][Full Text] [Related]
12. Alpha-galactosylceramide (αGalCer) enhances vaccine-induced protection in a model of ricin intoxication.
Yates JL; Leadbetter E; Mantis NJ
Hum Vaccin Immunother; 2018; 14(8):2053-2057. PubMed ID: 29617191
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.
Hassett KJ; Cousins MC; Rabia LA; Chadwick CM; O'Hara JM; Nandi P; Brey RN; Mantis NJ; Carpenter JF; Randolph TW
Eur J Pharm Biopharm; 2013 Oct; 85(2):279-86. PubMed ID: 23583494
[TBL] [Abstract][Full Text] [Related]
14. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin.
Smallshaw JE; Richardson JA; Pincus S; Schindler J; Vitetta ES
Vaccine; 2005 Sep; 23(39):4775-84. PubMed ID: 15961194
[TBL] [Abstract][Full Text] [Related]
15. Localization of non-linear neutralizing B cell epitopes on ricin toxin's enzymatic subunit (RTA).
O'Hara JM; Kasten-Jolly JC; Reynolds CE; Mantis NJ
Immunol Lett; 2014; 158(1-2):7-13. PubMed ID: 24269767
[TBL] [Abstract][Full Text] [Related]
16. Folding domains within the ricin toxin A subunit as targets of protective antibodies.
O'Hara JM; Neal LM; McCarthy EA; Kasten-Jolly JA; Brey RN; Mantis NJ
Vaccine; 2010 Oct; 28(43):7035-46. PubMed ID: 20727394
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a ricin vaccine candidate (RVEc) for human toxicity using an in vitro vascular leak assay.
Porter A; Phillips G; Smith L; Erwin-Cohen R; Tammariello R; Hale M; DaSilva L
Toxicon; 2011 Jul; 58(1):68-75. PubMed ID: 21616091
[TBL] [Abstract][Full Text] [Related]
18. A pilot clinical trial of a recombinant ricin vaccine in normal humans.
Vitetta ES; Smallshaw JE; Coleman E; Jafri H; Foster C; Munford R; Schindler J
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2268-73. PubMed ID: 16461456
[TBL] [Abstract][Full Text] [Related]
19. Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection.
Roy CJ; Brey RN; Mantis NJ; Mapes K; Pop IV; Pop LM; Ruback S; Killeen SZ; Doyle-Meyers L; Vinet-Oliphant HS; Didier PJ; Vitetta ES
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3782-7. PubMed ID: 25775591
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of nested neutralizing and non-neutralizing B cell epitopes on ricin toxin's enzymatic subunit.
Rudolph MJ; Vance DJ; Cassidy MS; Rong Y; Shoemaker CB; Mantis NJ
Proteins; 2016 Aug; 84(8):1162-72. PubMed ID: 27159829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
